| 2024-02-16 |
详情>>
股本变动：
变动后总股本453.20万股
变动原因 ▼▲
- 原因：
- From September 30, 2023 to November 13, 2023
Common shares issued in relation with the settlement of a litigation
|
| 2024-02-16 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-15.11美元,归母净利润-2695.39万美元,同比去年增长20.48%
|
| 2023-11-14 |
详情>>
业绩披露：
2024年中报每股收益-17.48美元,归母净利润-920.46万美元,同比去年增长73.84%
|
| 2023-09-18 |
复牌提示：
2023-09-18 09:41:59 停牌，复牌日期 2023-09-18 09:51:59
|
| 2023-09-08 |
详情>>
拆分方案：
每40.0000合并分成1.0000股
|
| 2023-09-06 |
详情>>
业绩披露：
2024年一季报每股收益-0.51美元,归母净利润-831.44万美元,同比去年增长-94.06%
|
| 2023-07-17 |
详情>>
业绩披露：
2023年年报每股收益-5.12美元,归母净利润-6045.97万美元,同比去年增长19.36%
|
| 2023-03-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-4.01美元,归母净利润-3389.37万美元,同比去年增长35.55%
|
| 2022-12-20 |
详情>>
业绩披露：
2023年中报每股收益-6.26美元,归母净利润-3518.18万美元,同比去年增长-3.68%
|
| 2022-12-16 |
财报披露：
美东时间 2022-12-16 盘后发布财报
|
| 2022-08-19 |
股东大会：
将于2022-09-27召开股东大会
会议内容 ▼▲
- 1.To receive the financial statements of the Corporation for the financial year ended March 31, 2022 and the auditor’s report thereon;
2.To elect the directors of the Corporation for the ensuing year;
3.To appoint the auditor for the ensuing year and to authorize the directors of the Corporation to fix its compensation;
4.The adoption of an advisory (non-binding) resolution on the compensation of the Corporation’s named executive officers, as more particularly described in the accompanying management information circular and proxy statement (the “Proxy Statement”);
5.The adoption of an advisory (non-binding) resolution on the frequency of future “say on pay” votes, as more particularly described in the accompanying Proxy Statement;
6.To consider and, if deemed appropriate, pass, with or without variation, an ordinary resolution confirming and ratifying the adoption of the amended and restated by-laws of the Corporation as described in the accompanying Proxy Statement;
7.To transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2022-08-15 |
详情>>
业绩披露：
2023年一季报每股收益-1.09美元,归母净利润-428.44万美元,同比去年增长74.66%
|
| 2022-07-08 |
详情>>
业绩披露：
2022年年报每股收益-17.5美元,归母净利润-7497.17万美元,同比去年增长39.13%
|
| 2022-06-13 |
详情>>
拆分方案：
每35.0000合并分成1.0000股
|
| 2022-04-01 |
详情>>
内部人交易：
Cammarata Michael共交易2笔
|
| 2022-02-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.32美元,归母净利润-5259.14万美元,同比去年增长51.42%
|
| 2021-11-15 |
详情>>
业绩披露：
2022年中报每股收益-0.2美元,归母净利润-3393.32万美元,同比去年增长-1.63%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-02 |
股东大会：
将于2021-08-26召开股东大会
会议内容 ▼▲
- 1.to receive the financial statements of the Corporation for the financial year ended March 31, 2021 and the auditor’s report thereon;
2.to elect the directors of the Corporation for the ensuing year;
3.to appoint the auditor for the ensuing year and to authorize the directors of the Corporation to fix its compensation;
4.to approve renewal of the Corporation’s stock option plan;
5.to approve renewal of the Corporation’s equity incentive plan;
6.to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2020-07-16 |
股东大会：
将于2020-08-12召开股东大会
会议内容 ▼▲
- 1.to receive the consolidated financial statements of the Corporation for the financial year ended March 31, 2020 and the auditor’s report thereon;
2.to elect the directors of the Corporation for the ensuing year;
3.to appoint the auditor for the ensuing year and to authorize the directors of the Corporation to fix its remuneration;
4.to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2019-07-18 |
股东大会：
将于2019-08-14召开股东大会
会议内容 ▼▲
- 1.to receive the financial statements of the Corporation for the financial year ended March 31, 2019 and the auditors’ report thereon;
2.to elect the directors of the Corporation for the ensuing year;
3.to appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration;
4.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving certain amendments to the Corporation’s stock option plan and equity incentive plan, and ratifying and confirming the grant of 7,800,000 options to purchase common shares of the Corporation to Michael Cammarata, as more particularly described in the accompanying Circular;
5.to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2018-07-18 |
股东大会：
将于2018-08-15召开股东大会
会议内容 ▼▲
- 1.to receive the financial statements of the Corporation for the financial year ended March 31, 2018 and the auditors’ report thereon;
2.to elect the directors of the Corporation for the ensuing year;
3.to appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration;
4.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving the unallocated options under the Corporation’s stock option plan, as more particularly described in the accompanying management information circular (the “Circular”);
5.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving, ratifying and confirming certain amendments to the Corporation’s stock option plan, as previously approved by the board of directors of the Corporation (the “Board”), as more particularly described in the Circular;
6.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving, ratifying and confirming the grant of 2,095,333 options to purchase common shares of the Corporation to certain executives and Board members, as previously approved by the Board, as more particularly described in the Circular;
7.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving the unallocated entitlements under the Corporation’s equity incentive plan, as more particularly described in the Circular;
8.to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution approving, ratifying and confirming certain amendments to the Corporation’s equity incentive plan, as previously approved by the Board, as more particularly described in the Circular;
9.to consider and, if deemed appropriate, to pass, with or without variation, a special resolution approving, ratifying and confirming a change of name of the Corporation from “Neptune Technologies & Bioressources Inc.” to “Neptune Wellness Solutions Inc.” / “Neptune Solutions Bien-être Inc.”;
10.to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2017-07-17 |
股东大会：
将于2017-08-15召开股东大会
会议内容 ▼▲
- 1.to receive the financial statements of the Corporation for the financial year ended March 31, 2017 and the auditors’ report thereon;
2.to elect the directors of the Corporation for the ensuing year;
3.to appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration;
4.to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2016-06-14 |
股东大会：
将于2016-07-12召开股东大会
会议内容 ▼▲
- 1. to receive the financial statements of the Corporation for the financial year ended February 29, 2016 and the auditors' report thereon;
2. to elect the directors of the Corporation for the ensuing year;
3. to appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration;
4. to consider and, if deemed appropriate, to adopt an ordinary resolution (the text of which is reproduced in the accompanying management proxy circular ("Circular") and described in section "Particulars of Matters to be Acted Upon" under "Renewal of Equity Incentive Plan") approving the Corporation's equity incentive plan, as approved by the board of directors of the Corporation on May 25, 2016
5. to transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2015-06-18 |
股东大会：
将于2015-07-14召开股东大会
会议内容 ▼▲
- 1.To receive the financial statements of the Corporation for the financial year ended February 28, 2015 and the auditors’ report thereon;
2.To elect the directors of the Corporation for the ensuing year;
3.To appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration;
4.To consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution to approve the unallocated entitlements under the Corporation’s existing 15% rolling stock option plan for the ensuing three years, and related matters;
5.To consider and, if deemed appropriate, pass, with or without variation, an ordinary resolution confirming and ratifying the adoption of the amended and restated general by-law of the Corporation as described in the accompanying management information circular;
6.To transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2014-05-28 |
股东大会：
将于2014-06-19召开股东大会
会议内容 ▼▲
- 1. To receive the financial statements of the Corporation for the financial year ended February 28, 2014 and the auditors’ report thereon;
2. To consider and, if deemed advisable, to pass, with or without variation, a special resolution (the full text of which is set out in the accompanying management information circular) to amend the Corporation’s articles to increase the maximum number of directors from six to ten;
3. To elect the directors of the Corporation for the ensuing year;
4. To appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their compensation;
5. To transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|
| 2013-05-28 |
股东大会：
将于2013-06-27召开股东大会
会议内容 ▼▲
- 1. To receive the financial statements of the Corporation for the financial year ended February 28, 2013 and the auditors’ report thereon;
2. To elect the directors of the Corporation for the ensuing year;
3. To appoint the auditors for the ensuing year and to authorize the directors of the Corporation to fix their compensation;
4. To consider and, if deemed appropriate, to adopt a resolution (the text of which is reproduced in the accompanying management proxy circular (“Circular”) and described in section “Particulars of Matters to be Acted Upon” under “Approval of Equity Incentive Plan”) confirming and approving the Corporation’s Equity Incentive Plan, as approved by the board of directors of the Corporation on January 30, 2013;
5. To consider and, if deemed appropriate, to adopt a resolution (the text of which is reproduced in Circular and described in section “Particulars of Matters to be Acted Upon” under “Renewal of the Shareholders Rights Plan”) approving the Corporation’s Shareholder Rights Plan, as approved by the Board of Directors on May 9, 2013;
6. To consider and, if deemed appropriate, to adopt a resolution (the text of which is reproduced in Circular and described in section “Particulars of Matters to be Acted Upon” under “Adoption of By-Law 2013-1”) to ratify the advance notice by-law, as approved by the Board of Directors on May 9, 2013;
7. To transact such other business as may properly be brought before the Meeting or any adjournment thereof.
|